As Malaysia experiences a demographic shift towards an ageing population, the significance of adult immunisation is becoming increasingly evident. Ensuring that individuals receive necessary vaccinations not only keeps them healthy and active participants in society and the economy but also prolongs productivity, maintains contributions to local economies, and reduces healthcare costs, particularly as they enter their golden years. This World Immunisation Week, observed from April 24th to April 30th, highlights the critical role of vaccination in promoting health and socioeconomic well-being globally, with a special focus on Malaysia.
Recent data from the Department of Statistics Malaysia (DOSM) indicates a notable increase in the number of individuals aged 65 years and above, with approximately 2.5 million falling into this category. DOSM projections suggest that by 2040, Malaysia will have nearly equal shares of the young (18.6%) and older (14.5%) populations. This forecast indicates that in less than two decades, the older population in Malaysia will surpass 6.0 million, marking a transition to an aged society.
In line with World Immunisation Week 2024, GlaxoSmithKline (GSK) organized a timely discussion, bringing together local and global experts to share insights on the evolving vaccine landscape, the importance of vaccines in older adults, and the socio-economic value of adult immunisation. The event also included a local panel discussion that featured in-depth conversations about the prevention of vaccine-preventable diseases (VPDs) among Malaysian adults, challenges faced by the healthcare industry, and opportunities to transition towards a healthier ageing society.
Dr. Thanabalan Fonseka, Vaccines Medical Director of GSK Malaysia, emphasized the need for increased awareness and accessibility of adult vaccinations. He noted that while childhood immunisation initiatives are well-established with high coverage rates, the primary challenge lies in the lack of awareness among adults about VPDs and their preventive options. Additionally, logistical hurdles such as limited access to healthcare services and financial constraints further hinder adult vaccination rates. Dr. Fonseka stressed the urgency of elevating awareness, enhancing accessibility, and prioritizing adult vaccinations to ensure comprehensive protection against preventable diseases throughout adulthood.
Adult vaccinations include a range of vaccines recommended for individuals in adulthood to protect against various diseases such as COVID-19, influenza, pneumococcal disease, herpes zoster, and respiratory syncytial virus. Adults over the age of 50 are particularly at risk due to factors like declining immune systems, underlying health conditions, and decreased vaccine immunity over time. However, individuals of all ages, especially those with weakened immune systems due to conditions like HIV/AIDS or cancer, may be vulnerable to infectious diseases.
During World Immunisation Week, GSK is advocating for the importance of adult immunisation globally. By raising awareness about the health, structural, and socioeconomic benefits of adult vaccines, GSK aims to support the World Health Organisation’s Expanded Programme on Immunization (EPI) and save lives through immunisation. With a commitment to prevention as the cornerstone of healthcare, GSK continues to play a crucial role in protecting individuals of all ages, reshaping policy around adult immunisation, and contributing to public health in Malaysia.
